Daily Mail on Minnesota
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus
Minnesota Non-Local Sources
•
Nov 30, 2022
Biogen
Latest Minnesota stories tagged “Biogen”.
Daily Mail on Minnesota
Daily Mail on Minnesota
Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focus
Minnesota Non-Local Sources
•
Nov 30, 2022
Daily Mail on Minnesota
Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline
Minnesota Non-Local Sources
•
Sep 28, 2022
Winona Daily News
The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm
Southern Minnesota
•
Apr 14, 2022
Twincities.com | St. Paul Pioneer
Lisa Jarvis: Medicare is cleaning up the FDA's mess on Biogen's Alzheimer's drug
Twin Cities
•
Apr 12, 2022
Star Tribune
Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug
Twin Cities
•
Oct 20, 2021
Star Tribune Politics
Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug
Minnesota Politics
•
Oct 20, 2021
Bemidji Pioneer
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
Northwest Minnesota
•
Jul 26, 2021
Wadena Pioneer Journal
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
Central Minnesota
•
Jul 26, 2021
Perham Focus
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
West Central Minnesota
•
Jul 26, 2021
Lake County News Chronicle | Two Harbors
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
Northland Minnesota
•
Jul 26, 2021
West Central Tribune | Willmar
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
Southwest Minnesota
•
Jul 26, 2021
Daily Mail on Minnesota
First patient set to receive controversial Biogen Alzheimer's drug
Minnesota Non-Local Sources
•
Jun 16, 2021
St. Cloud Times
FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades
Central Minnesota
•
Jun 7, 2021
Twincities.com | St. Paul Pioneer
Massachusetts superspreader: Biogen conference tied to 300,000 coronavirus cases
Twin Cities
•
Dec 11, 2020
Brainerd Dispatch
U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer's drug
Central Minnesota
•
Nov 6, 2020
West Central Tribune | Willmar
U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer's drug
Southwest Minnesota
•
Nov 6, 2020
Lake County News Chronicle | Two Harbors
U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer's drug
Northland Minnesota
•
Nov 6, 2020
Twincities.com | St. Paul Pioneer
Biotech conference in Boston continues to be leading source of Mass. coronavirus cases
Twin Cities
•
Mar 10, 2020
KLGR Radio Redwood Falls
In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer's drug
Southwest Minnesota
•
Oct 22, 2019